Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fabry Disease D000795 4 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Le Stunff H et al. Generation and metabolism of bioactive sphingosine-1-phosphate. 2004 J. Cell. Biochem. pmid:15258913
Muehlich S et al. Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. 2004 Atherosclerosis pmid:15262182
Duan HF et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. 2004 Exp. Cell Res. pmid:15265705
Melendez AJ and Ibrahim FB Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis. 2004 J. Immunol. pmid:15265887
Anliker B and Chun J Cell surface receptors in lysophospholipid signaling. 2004 Semin. Cell Dev. Biol. pmid:15271291
Pyne S et al. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. 2004 Semin. Cell Dev. Biol. pmid:15271294
Hla T Physiological and pathological actions of sphingosine 1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271296
Payne SG et al. Modulation of adaptive immune responses by sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271297
Oskouian B and Saba JD Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate. 2004 Semin. Cell Dev. Biol. pmid:15271298
Matsushita K et al. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15273282
Augé N et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. 2004 Circulation pmid:15277330
McVerry BJ et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:15282202
Ogretmen B and Hannun YA Biologically active sphingolipids in cancer pathogenesis and treatment. 2004 Nat. Rev. Cancer pmid:15286740
Gonzalez E et al. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. 2004 J. Biol. Chem. pmid:15292187
Lockman K et al. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. 2004 J. Biol. Chem. pmid:15292266
Lee H et al. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. 2004 Am. J. Physiol., Cell Physiol. pmid:15294853
Kang YC et al. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. 2004 Cell Death Differ. pmid:15297884
Holdsworth G et al. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor. 2004 BMC Biochem. pmid:15298705
Roth Z and Hansen PJ Sphingosine 1-phosphate protects bovine oocytes from heat shock during maturation. 2004 Biol. Reprod. pmid:15317688
Hemmings DG et al. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. 2004 Br. J. Pharmacol. pmid:15326035
Panetti TS et al. Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. 2004 J. Thromb. Haemost. pmid:15333043
Waeber C et al. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. 2004 Jul-Aug Drug News Perspect. pmid:15334188
Clemens JJ et al. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. 2004 Bioorg. Med. Chem. Lett. pmid:15341948
Grey A et al. Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate. 2004 Calcif. Tissue Int. pmid:15354862
Argraves KM et al. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. 2004 J. Biol. Chem. pmid:15377653
Jin ZQ et al. Sphingosine kinase activation mediates ischemic preconditioning in murine heart. 2004 Circulation pmid:15451787
Allende ML et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. 2004 J. Biol. Chem. pmid:15459201
Liu S et al. Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. 2004 J. Biol. Chem. pmid:15466414
Xin C et al. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. 2004 Br. J. Pharmacol. pmid:15466446
Birukov KG et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. 2004 Circ. Res. pmid:15472119
Kumar A et al. Sphingosine-1-phosphate plays a role in the suppression of lateral pseudopod formation during Dictyostelium discoideum cell migration and chemotaxis. 2004 Cell Motil. Cytoskeleton pmid:15476260
Yamanaka M et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. 2004 J. Biol. Chem. pmid:15485866
McVerry BJ and Garcia JG In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. 2005 Cell. Signal. pmid:15494205
Waters CM et al. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. 2005 Cell. Signal. pmid:15494217
Sun C and Bittman R An efficient preparation of isosteric phosphonate analogues of sphingolipids by opening of oxirane and cyclic sulfamidate intermediates with alpha-lithiated alkylphosphonic esters. 2004 J. Org. Chem. pmid:15497998
Wang FX et al. mitochondrial ceramidase overexpression up-regulates Bcl-2 protein level in K562 cells, probably through its metabolite sphingosine-1-phosphate. 2004 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15498114
Nakamura H et al. Effects of synthetic sphingosine-1-phosphate analogs on arachidonic acid metabolism and cell death. 2004 Biochem. Pharmacol. pmid:15498509
Alewijnse AE et al. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. 2004 Br. J. Pharmacol. pmid:15504747
Bhattacharya J Lung injury: sphingosine-1-phosphate to the rescue. 2004 Am. J. Respir. Crit. Care Med. pmid:15504814
Itagaki K et al. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. 2005 J. Leukoc. Biol. pmid:15522918
Hedemann J et al. Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. 2004 Auton Autacoid Pharmacol pmid:15541015
Amano S et al. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. 2004 Br. J. Dermatol. pmid:15541073
Levkau B et al. High-density lipoprotein stimulates myocardial perfusion in vivo. 2004 Circulation pmid:15545521
Galaria II et al. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. 2004 J. Surg. Res. pmid:15555614
Shida D et al. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. 2004 FEBS Lett. pmid:15556605
Watterson KR et al. The role of sphingosine-1-phosphate in smooth muscle contraction. 2005 Cell. Signal. pmid:15567060
Elices MJ Editorial overview: Tie me up, tie me down: immunosuppressive therapies for the 21st century. 2004 Curr Opin Investig Drugs pmid:15573862
Lee C et al. Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. 2004 J Trauma pmid:15580017
Tamama K et al. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. 2005 Atherosclerosis pmid:15585196
Zhang B et al. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. 2005 Atherosclerosis pmid:15585219